Papillary Serous and Clear Cell Carcinoma Limited to Endometrial Curettings in FIGO Stage 1a and 1b Endometrial Adenocarcinoma: Treatment Implications

By Aquino-Parsons C.   Lim P.   Wong F.   Mildenberger M.  

Gynecologic Oncology, Vol. 71, Iss. 1, 1998-10 ,pp. : 83-86

Elsevier

Access to resources Recommend Favorite

Predictors of Recurrence in Surgical Stage II Endometrial Adenocarcinoma

By Feltmate C.M.   Duska L.R.   Chang Y.   Flynn C.E.   Nikrui N.   Kiggundu E.   Goodman A.   Fuller A.F.   McIntyre J.F.  

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 407-411

Elsevier

Access to resources Recommend Favorite

Endometrial adenocarcinoma with coexisting adenomatoid tumor of the uterus

By Cserni G.   Kocsis L.   Pusztai Z.   Godo G.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 207-210

Elsevier

Access to resources Recommend Favorite

Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor

By Hoebers F.   Pluim D.   Hart A.   Verheij M.   Balm A.   Fons G.   Rasch C.   Schellens J.   Stalpers L.   Bartelink H.   Begg A.  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 1075-1081

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Outcomes of Therapeutic Pelvic Lymphadenectomy for Stage I Endometrial Adenocarcinoma

By Mohan D.S.   Samuels M.A.   Selim M.A.   Shalodi A.D.   Ellis R.J.   Samuels J.R.   Yun H.J.  

Gynecologic Oncology, Vol. 70, Iss. 2, 1998-08 ,pp. : 165-171

Elsevier

Access to resources Recommend Favorite